Search results
AstraZeneca pulls Covid vaccine after admitting rare side effect
Daily Express· 3 days agoThe Oxford-AstraZeneca Covid vaccine is set to be withdrawn after the pharmaceutical giant admitted...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 12 hours agoThe FDA cited administrative constraints for the delay, Cambridge, Mass.-based Moderna said in a...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 13 hours agoThe FDA has informed Moderna that it is working to conclude...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 3 hours agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...
France’s Sanofi in COVID-19 vaccine deal with Novavax
KFGO· 17 hours agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
AstraZeneca pulls its COVID-19 vaccine from Europe
Boston Herald· 1 day agoAstraZeneca’s COVID-19 vaccine was first given the nod by the EMA in January 2021.
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 10 hours agoUnder the terms of the agreement, Sanofi will begin to book sales of Novavax’s COVID-19 vaccine...
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 3 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 4 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 6 hours ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...